Judge Nixes Abbott's Patent Defense In Norvir Case
A judge knocked out a major part of Abbott Laboratories' defense against an antitrust suit related to its HIV treatment Norvir, ruling Friday that claims in two of Abbott's patents for...To view the full article, register now.
Already a subscriber? Click here to view full article